GlobeNewswire Inc | Jul 13, 2021 04:05PM EDT

July 13, 2021

REDWOOD CITY, Calif., July 13, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the second quarter 2021 after market close on Thursday, August 12, 2021. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the Investor section of Seers website at investor.seer.bio. An archived replay will be available on the companys website following the event.

About SeerSeeris a life sciences company developing transformative products that open up a new gateway to the proteome.Seeris commercializing its Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours.Seerdesigned the Proteograph workflow to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be adopted by nearly any lab.Seers Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visitwww.seer.bio.

Investor ContactCarrie Mendivilinvestor@seer.bio

Media ContactKaren Possematopr@seer.bio